| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/1995 | US5387601 Medicament |
| 02/07/1995 | US5387600 Treating arteriosclerosis using benzimidazole compositions |
| 02/07/1995 | US5387598 Nitazoxanide, wetting agent, and starch derivative |
| 02/07/1995 | US5387594 Administering for topical and systemic treatment of |
| 02/07/1995 | US5387593 Anxiolytic agents |
| 02/07/1995 | US5387592 Angiotensin converting enzyme inhibitors, calcium channel blockers, diuretics and adrenergic blocking agents |
| 02/07/1995 | US5387591 Pyrrolidine compounds |
| 02/07/1995 | US5387590 Analgesics |
| 02/07/1995 | US5387589 Administering rapamycin |
| 02/07/1995 | US5387586 (Aryl(alkyl)carbonyl)-heterocyclic compounds, compositions and use |
| 02/07/1995 | US5387585 Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia |
| 02/07/1995 | US5387584 Bicyclic ansamycins |
| 02/07/1995 | US5387583 Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof |
| 02/07/1995 | US5387582 Vitamin D analogues |
| 02/07/1995 | US5387581 Pharmaceutical composition of aspirin and a benzothiazepine for inhibiting platelet aggregation |
| 02/07/1995 | US5387579 Use of α-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained |
| 02/07/1995 | US5387578 Releasing drugs from bioactive agents in order to improve the therapeutic efficacy and reduce their toxic effects |
| 02/07/1995 | US5387520 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors |
| 02/07/1995 | US5387509 Antiparasitic agents |
| 02/07/1995 | US5387420 Storage stability |
| 02/07/1995 | CA2129565A1 Oligonucleotide compounds, their production and use |
| 02/07/1995 | CA2103516A1 Therapeutical application of fluoroquinolone derivatives |
| 02/07/1995 | CA2083945C An antiviral composition |
| 02/07/1995 | CA2030911C Pharmaceutical preparations |
| 02/07/1995 | CA2029704C Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| 02/07/1995 | CA2028514C Treatment of depression |
| 02/07/1995 | CA1334294C Substituted imidazol¬2,1-b|quinazolin-5(3h)-ones and related tricyclic compounds |
| 02/07/1995 | CA1334281C Emulsion for parenteral administration |
| 02/06/1995 | CA2129483A1 Bicyclic derivatives of imidazole, process for their preparation, new intermediate compounds thus obtained, their application as medicaments, and pharmaceutical compositions containing them |
| 02/06/1995 | CA2129462A1 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives |
| 02/06/1995 | CA2129374A1 Carbonamides, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/05/1995 | CA2103938A1 Method and composition for revitalizing scar tissue |
| 02/04/1995 | CA2129301A1 Benzo-fused heterocyclic compounds with a 5-membered ring, process for their preparation, their use as medicaments, their use as diagnostic agents, and medicaments containing them |
| 02/03/1995 | CA2129279A1 Pharmaceutical composition and process |
| 02/03/1995 | CA2129274A1 Pharmaceutical composition |
| 02/03/1995 | CA2129179A1 Trisubstituted pyrimido[5,4-d]pyrimidines for modulating multi-drug resistance, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/03/1995 | CA2129099A1 Pharmaceutical compositions having good dissolution properties |
| 02/02/1995 | WO1995003407A2 Oligonucleotides with activity against human immunodeficiency virus |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003319A1 Cyproterone acetate thioacetate |
| 02/02/1995 | WO1995003317A1 Antiparasitic agents |
| 02/02/1995 | WO1995003313A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them |
| 02/02/1995 | WO1995003312A1 Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus |
| 02/02/1995 | WO1995003307A1 Brain cell protective |
| 02/02/1995 | WO1995003305A1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003303A2 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 02/02/1995 | WO1995003302A1 Quinolizidines with calcium channel antagonistic activity |
| 02/02/1995 | WO1995003301A1 Azalicyclooctane derivatives as anti-arrhythmic agents |
| 02/02/1995 | WO1995003298A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST |
| 02/02/1995 | WO1995003295A1 Endothelin antagonists |
| 02/02/1995 | WO1995003292A1 Heteroaryl cycloalkenyl hydroxyureas |
| 02/02/1995 | WO1995003290A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | WO1995003285A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | WO1995003284A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | WO1995003283A1 Quinazoline derivatives and their use as anti-cancer agents |
| 02/02/1995 | WO1995003281A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 02/02/1995 | WO1995003273A1 Vitamin d analogues |
| 02/02/1995 | WO1995003271A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/02/1995 | WO1995003270A1 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds |
| 02/02/1995 | WO1995003266A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | WO1995003061A1 Preparation for improving the blood supply containing hard magnetic particles |
| 02/02/1995 | WO1995003060A1 Compositions and methods for reducing salmonella in chickens |
| 02/02/1995 | WO1995003059A1 Bivalent sialyl lewis x saccharides |
| 02/02/1995 | WO1995003057A1 Endotoxin neutralizer |
| 02/02/1995 | WO1995003056A1 Hepatitis c virus proliferation inhibitor |
| 02/02/1995 | WO1995003055A1 At-2 antagonist inhibition of vascular restenosis |
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003053A1 Oxophthalazines for treating cachexia |
| 02/02/1995 | WO1995003052A1 Controlled release tacrine drug delivery systems and methods for preparing same |
| 02/02/1995 | WO1995003051A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock |
| 02/02/1995 | WO1995003050A2 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 02/02/1995 | WO1995003048A1 Anti-hiv azaspiranes |
| 02/02/1995 | WO1995003047A1 Human immunodeficiency virus treatments |
| 02/02/1995 | WO1995003046A1 A method of inhibiting the production of hiv |
| 02/02/1995 | WO1995003045A1 Accelerator for digestive tract movement |
| 02/02/1995 | WO1995003043A1 Sustained release oral compositions containing melatonin |
| 02/02/1995 | WO1995003042A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | WO1995003041A1 Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | WO1995003040A1 Pharmaceutical compositions containing as active agent isoflavone derivatives or salts thereof |
| 02/02/1995 | WO1995003039A1 N,n,n-trimethylsphingosine derivatives |
| 02/02/1995 | WO1995003038A1 Treatment of tachyarrhythmias of supraventricular origin |
| 02/02/1995 | WO1995003037A1 Method of treating alcohol dependence |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | WO1995002969A1 A maltodextrin composition |
| 02/02/1995 | WO1995002967A1 Viscous liquid xylitol compositions and method for preparing same |
| 02/02/1995 | WO1995002960A1 Louse repellent compositions |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994028907A3 Use of corrinoids in topical treatment of skin diseases |
| 02/02/1995 | WO1994027587A3 Sustained antiepileptic therapy |
| 02/02/1995 | WO1994027583A3 Apoptosis inhibitors for treating neurodegenerative diseases |
| 02/02/1995 | WO1994026723A3 ras FARNESYL TRANSFERASE INHIBITORS |
| 02/02/1995 | WO1994024984A3 Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto |
| 02/02/1995 | WO1994004222A3 Adjunctive photodynamic therapy for treating cardiovascular disease |
| 02/02/1995 | DE4400770C1 Plaster containing an active substance for delivery of oestradiol with at least one penetration enhancer, method of producing it and its use |